about
Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapyBone Metastasis from Renal Cell Carcinomac-Met as a Target for Personalized TherapyMet in urological cancersIn silico identification of potential key regulatory factors in smoking-induced lung cancer.Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth.Expression and significance of histone H3K27 demethylases in renal cell carcinoma.Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis.Signaling pathways in renal cell carcinoma.Glaucocalyxin A, a negative Akt regulator, specifically induces apoptosis in human brain glioblastoma U87MG cells.Piperlongumine and its analogs down-regulate expression of c-Met in renal cell carcinoma.c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinomaVascular disruption in combination with mTOR inhibition in renal cell carcinoma.C-met inhibition blocks bone metastasis development induced by renal cancer stem cells.Current Concepts in Non-Gastrointestinal Stromal Tumor Soft Tissue Sarcomas: A Primer for Radiologists.Genetic profiles in renal tumors.Rereading the renal cell tumors.Non-clear cell renal cell carcinoma: how new biological insight may lead to new therapeutic modalities.Acquired cystic disease-associated renal cell carcinoma: further characterization of the morphologic and immunopathologic features.A phase I study of cabozantinib (XL184) in patients with renal cell cancer.Emerging drugs for the treatment of bone metastasis.Clinical Pharmacokinetics and Pharmacodynamics of Cabozantinib.Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy.Hepatocyte growth factor induces breast cancer cell invasion via the PI3K/Akt and p38 MAPK signaling pathways to up-regulate the expression of COX2.MET in type 1 papillary renal cell carcinoma3rd Pavia international symposium on advanced kidney cancer.Dysregulated HAI-2 Plays an Important Role in Renal Cell Carcinoma Bone Metastasis through Ligand-Dependent MET Phosphorylation.Non-Clear Cell Renal Cell Carcinoma: Current Management and Best Practice
P2860
Q26741450-20D32738-A7F0-45F3-AA5A-99BF8A6C3A73Q26747493-96EEF4D5-7631-4CD8-BFC5-437258DFC41FQ26775483-F75DB4D0-2A55-4868-A151-BA30CB2FD69CQ26864988-84E2302D-1C80-44C6-AC4B-91D8BD0FDC53Q33776567-DF0BDA68-D41F-47DC-8E43-7CBD691AE6AFQ33919087-334C2BC9-A472-47DA-B900-D907E41F4587Q34443684-854E4474-DB6D-4563-86A4-97FB8124077CQ34854941-55ABAEFF-6725-439C-8EE8-A255ECEB087DQ34978827-E7227D00-7631-4D9D-8749-BF30DA65ECDAQ34991079-D1F03E38-35A4-408F-AAFA-1F5FAE036C1FQ36214648-ACDB8802-25D7-4AC0-9952-D11974FEE365Q36551653-43CD151A-00A4-42A8-A3D1-6AC6C98063C2Q37154148-C27A3F96-6FAB-40AC-A6E0-671F64395704Q37564471-E5F3DA77-FFD6-4CA1-BCEB-B2369789170EQ37589535-8A190B03-6FF4-48D1-8564-16A36EBC261BQ37615533-BBFFB3E9-EF3C-4D66-93E8-08C158E72DF2Q37756379-EB27EB1E-B07A-4F10-8D9C-76A113E269C8Q37836508-8EEFAD85-92B6-445C-BBB8-9BEECCAFD168Q38087558-A43CBBA4-B040-408F-9CCB-D1F40C59F3D7Q38430335-0D734EB8-35C1-4312-80CF-47E6DA9DA69CQ38538263-79C33691-0B4B-4CAF-A441-27B3A774C575Q38979283-C2E4281C-FBAB-4747-B0CB-E20D1192AC97Q39614066-AA50A80E-C87C-4A89-9CA2-FA19BE02D395Q40061883-FECD4A7E-3A5A-42D4-95D5-D8AC241F8AEBQ50400632-9AD700EF-1AAF-4173-98DA-9A38477392C5Q53137044-9FB06483-327F-439E-B81A-FD247564674FQ55515387-70DD1FAD-0377-48A7-A60C-0E1118CD0BBBQ58585079-75EE0127-CFB5-4FF4-97F8-0573A8932601
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting the Met signaling pathway in renal cancer.
@en
Targeting the Met signaling pathway in renal cancer.
@nl
type
label
Targeting the Met signaling pathway in renal cancer.
@en
Targeting the Met signaling pathway in renal cancer.
@nl
prefLabel
Targeting the Met signaling pathway in renal cancer.
@en
Targeting the Met signaling pathway in renal cancer.
@nl
P2860
P356
P1476
Targeting the Met signaling pathway in renal cancer
@en
P2093
W Marston Linehan
P2860
P304
P356
10.1586/ERA.09.43
P577
2009-06-01T00:00:00Z